MARC보기
LDR04088cam a2200637 i 4500
001000000480325
00520230210094531
006m d
007cr bn|||||||||
008220302s2022 dcu ob 100 0 eng
0167 ▼a 9918365947706676 ▼2 DNLM
019 ▼a 1293254271 ▼a 1294145727
020 ▼a 9780309269698
020 ▼a 0309269695
020 ▼a 9780309269759 ▼q (electronic bk.)
020 ▼a 030926975X ▼q (electronic bk.)
020 ▼z 9780309269674
020 ▼z 0309269679
035 ▼a 3165663 ▼b (N$T)
035 ▼a (OCoLC)1295270034 ▼z (OCoLC)1293254271 ▼z (OCoLC)1294145727
040 ▼a NLM ▼b eng ▼e rda ▼c NLM ▼d EBLCP ▼d UKAHL ▼d N$T ▼d 247004
042 ▼a pcc
050 4 ▼a QR189.5.I5
06000 ▼a WC 515
08204 ▼a 614.518 ▼2 23/eng/20230106
1001 ▼a Snair, Megan Reeve, ▼e rapporteur.
24510 ▼a International workshop on COVID-19 lessons to inform pandemic influenza response : ▼b proceedings of a workshop/ ▼c Megan Snair and Mariya Dimitrova, rapporteurs ; National Academy of Medicine.
264 1 ▼a Washington, DC : ▼b National Academies Press, ▼c [2022]
300 ▼a 1 online resource (1 PDF file (xii, 102 pages)).
336 ▼a text ▼b txt ▼2 rdacontent
337 ▼a computer ▼b c ▼2 rdamedia
338 ▼a online resource ▼b cr ▼2 rdacarrier
504 ▼a Includes bibliographical references.
5203 ▼a While the world continues to respond to the COVID-19 pandemic, novel influenza viruses persist as a constant pandemic threat. The global response to COVID-19 has pushed the boundaries on what is possible for rapid pandemic response in several areas, including vaccine research, development, manufacturing, equitable distribution, allocation, and administration. If well understood and sufficiently adapted, these actions could be applied to future pandemic and seasonal influenza vaccine preparedness efforts. However, developing and delivering these more effective vaccines to meet the demand goes beyond simply technical challenges and includes issues across governance, financing, research, supply chain, and public engagement. To address these challenges, the National Academies of Sciences, Engineering, and Medicine convened a virtual public workshop in May of 2021 to discuss the emerging evidence on unprecedented actions related to COVID-19 that could inform and advance pandemic and seasonal influenza vaccine preparedness efforts and subsequent response. This Proceedings of a Workshop provides a high-level summary of the presentations and discussions that occurred during the workshop.
536 ▼a This activity was supported by a contract between the National Academy of Sciences and the Office of Global Affairs with the U.S. Department of Health and Human Services. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project.
588 ▼a Description based on online resource; title from PDF title page (viewed July 29, 2022).
590 ▼a WorldCat record variable field(s) change: 050, 082, 650
650 0 ▼a Influenza vaccines.
650 0 ▼a Influenza ▼x Prevention.
650 0 ▼a Epidemics.
65012 ▼a Influenza Vaccines.
65022 ▼a Influenza, Human ▼x prevention & control.
65022 ▼a Vaccine Development.
65022 ▼a Pandemics.
65022 ▼a COVID-19.
65022 ▼a Internationality.
655 2 ▼a Congress.
7001 ▼a Dimitrova, Mariya, ▼e rapporteur,
7102 ▼a National Academy of Medicine (U.S.), ▼e issuing body.
7112 ▼a International Workshop on COVID-19: Lessons to Inform Pandemic Influenza Response ▼d (2021 : ▼c Online)
77608 ▼i Print version: ▼a Medicine, National Academy of ▼t International Workshop on COVID-19 Lessons to Inform Pandemic Influenza Response ▼d Washington, D.C. : National Academies Press,c2022 ▼z 9780309269674
85640 ▼3 EBSCOhost ▼u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=3165663
938 ▼a EBSCOhost ▼b EBSC ▼n 3165663
990 ▼a ***1818828
991 ▼a E-BOOK
994 ▼a 92 ▼b N$T